405
Views
36
CrossRef citations to date
0
Altmetric
Obstetrics

Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum

&
Pages 530-533 | Published online: 02 Jul 2009

References

  • Atanackovic G., Navioz Y., Moretti M.E. and Koren G. (2001) The safety of higher than standard dose of doxylamine—pyridoxine (Diclectin) for nausea and vomiting of pregnancy. Journal of Clinical Pharmacology, 41, 842–845.
  • Atanackovic G., Wolpin J. and Koren G. (2001) Determinants of the need for hospital care among women with nausea and vomiting of pregnancy. Clinical and Investigative Medicine, 24, 90–93.
  • Chandra K., Magee L. and Koren G. (2002) Discordence between physical symptoms versus perception of severity by women with NVP. BMC Pregnancy Childbirth, 2, 5.
  • Einarson A., Maltepe C., Navioz Y., Kennedy D., Tan M.P. and Koren G. (2002) The safety and effectiveness of ondansetron for the treatment of nausea and vomiting (NVP) [Abstract]. International Society of Pharmacoepide-miology, August, Edinburgh, Scotland.
  • Fairweather D.V. (1968) Nausea and vomiting in pregnancy. American Journal of Obstetrics and Gynecology, 102, 135–175.
  • Gadsby R., Barnie-Alshead A.M. and Jagger C. (1993) A prospective study of nausea and vomiting during pregnancy. British Journal of General Practice, 43, 245–248.
  • Goodwin T.M. (2002) Nausea and vomiting of pregnancy: an obstetric syndrome. American Journal of Obstetrics and Gynecology, 186 (Supplement 3), S184—S186.
  • Koren G., Boskovic R., Hard M., Maltepe C., Navioz Y. and Einarson A. (2002) Motherisk—PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. American Journal of Obstetrics and Gynecology, 185, S228— S231.
  • Mazzotta P. and Magee L.A. (2000) A risk benefit assessment of pharmacological and non pharmacological treatments of nausea and vomiting of pregnancy. Drugs, 59, 781–800.
  • Mazzotta P., Magee L.A., Maltepe C., Lifshitz A., Navioz Y. and Koren G. (1999) The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reproductive Toxicology, 13, 313–319.
  • Neutel C.I. (2000) Variation in rates of hospitalization for excessive vomiting in pregnancy by Bendectin/Diclectin use in Canada. In: Nausea and Vomiting of Pregnancy, State of the Art 2000, edited by Koren G. and Bishai R., pp. 54–59. Toronto, Motherisk Program.
  • Neutel C.I. and Johansen H.L. (1995) Measuring drug effectiveness by the case of Bendectin. Canadian Journal of Public Health, 86, 66–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.